Peter Kaiser

Professor of Ophthalmology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, and Senior Vice President of Product Development at Ohr Pharmaceutical

Actively involved in retinal clinical research, Kaiser has been the study chairman of seven major, multi-center international clinical trials and is a principal investigator in many others. Some of his innovations include the development of new vitreoretinal surgical techniques, pioneering the use of spectral domain OCT for the diagnosis and management of vitreoretinal disease, and being the first physician to use a modified RNA interfering molecule to treat AMD – a true colossus of the retina.

Part of the Power List 2016

Welcome to The Power List 2016 – our second foray into the Top 100 most influential people in the world of ophthalmology.

Though we realize our list can (and should) never be definitive, who can argue that the faces within – both familiar and new – do not beautifully highlight the brilliance and diversity found within the field?

Here, we celebrate 100 reasons to be proud of ophthalmology.

Go to The Power List 2016